for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Iradimed Corp

IRMD.OQ

Latest Trade

22.47USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

16.89

 - 

38.70

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
22.47
Open
--
Volume
--
3M AVG Volume
1.67
Today's High
--
Today's Low
--
52 Week High
38.70
52 Week Low
16.89
Shares Out (MIL)
11.37
Market Cap (MIL)
249.33
Forward P/E
32.25
Dividend (Yield %)
--

Latest Developments

More

IRadimed Corporation Announces Second Quarter 2019 Financial Results

Iradimed Corp Names Leslie Mcdonnell As President And CEO

IRadimed Posts Q1 Non-GAAP Earnings Per Share $0.13

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Iradimed Corp

IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.

Industry

Medical Equipment & Supplies

Contact Info

1025 Willa Springs Dr

+1.407.6778022

http://www.iradimed.com/en-us/

Executive Leadership

Roger Susi

Chairman of the Board, Founder, Chief Technology Officer

Leslie L. McDonnell

President, Chief Executive Officer, Director

Chris Scott

Chief Financial Officer, Corporate Secretary

John K. McCreery

Chief Operating Officer

Brent Johnson

Executive Vice President - Worldwide Sales and Marketing

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2016

0.700

2017

0.220

2018

0.540

2019(E)

0.720
Price To Earnings (TTM)
33.34
Price To Sales (TTM)
7.42
Price To Book (MRQ)
5.21
Price To Cash Flow (TTM)
27.30
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
17.84
Return on Equity (TTM)
16.14

Latest News

CORRECTED-BRIEF-IRadimed Corporation Q1 GAAP Earnings Per Share $0.07 (April 30)

* IRADIMED CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

CORRECTED-BRIEF-IRadimed Corporation Q1 GAAP Earnings Per Share $0.07 (April 30)

* IRADIMED CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-IRadimed Reports Q1 Non-GAAP EPS Of $0.10

* IRADIMED CORPORATION ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Iradimed Corporation Q4 EPS $0.02

* IRADIMED CORPORATION ANNOUNCES FOURTH QUARTER 2017 FINANCIAL RESULTS

BRIEF-Iradimed Sees Q1 2018 Non-GAAP EPS Of $0.06 To $0.07

* ORATION ANNOUNCES 2018 ANNUAL AND FIRST QUARTER FINANCIAL GUIDANCE

BRIEF-Iradimed Corporation says Q3 GAAP earnings per share $0.02

* Iradimed corporation announces third quarter 2017 financial results

BRIEF-Iradimed announces FDA 510(k) nod for MRI compatible patient vital signs monitor

* Iradimed corporation announces fda 510(k) clearance of MRI compatible patient vital signs monitor Source text for Eikon: Further company coverage:

BRIEF-Iradimed Corp reports Q2 EPS $0.03

* Iradimed Corp announces second quarter 2017 financial results

BRIEF-Iradimed posts Q1 adj. earnings per share $0.00

* Iradimed Corp - board of directors approved share repurchase program, authorizing repurchase of up to $8 million of co's common stock through April 28, 2018

BRIEF-Iradimed Corp Q4 non-GAAP EPS $0.11

* Iradimed Corporation announces fourth quarter 2016 financial results

BRIEF-Iradimed Corp reports 2017 annual and Q1 financial guidance

* Iradimed Corporation announces 2017 annual and first quarter financial guidance

BRIEF-Iradimed Corporation announces third quarter 2016 results

* Iradimed Corporation announces third quarter 2016 financial results

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up